Screener
Ionis Pharmaceuticals IONS Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
FAQ
- What is Ionis Pharmaceuticals's enterprise value?
- Ionis Pharmaceuticals (IONS) reported enterprise value of $13.02B in Q2 2026.
- How has Ionis Pharmaceuticals's enterprise value changed year-over-year?
- Ionis Pharmaceuticals's enterprise value increased by 91.2% year-over-year, from $6.81B to $13.02B.
- What is the long-term trend for Ionis Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's enterprise value has grown at a 13.4% compound annual growth rate (CAGR), from $7.93B to $14.91B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Ionis Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude